Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,044 hedge funds and large institutions have $44B invested in Allergan plc in 2018 Q2 according to their latest regulatory filings, with 110 funds opening new positions, 367 increasing their positions, 425 reducing their positions, and 83 closing their positions.
33% more first-time investments, than exits
New positions opened: 110 | Existing positions closed: 83
2% more funds holding
Funds holding: 1,022 → 1,044 (+22)
0% more funds holding in top 10
Funds holding in top 10: 45 → 45 (0)
4% less capital invested
Capital invested by funds: $45.8B → $44B (-$1.79B)
14% less repeat investments, than reductions
Existing positions increased: 367 | Existing positions reduced: 425
36% less call options, than puts
Call options by funds: $890M | Put options by funds: $1.39B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KSCM
King Street Capital Management
New York
|
+$174M |
| 2 |
State Street
Boston,
Massachusetts
|
+$167M |
| 3 |
BlackRock
New York
|
+$149M |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$136M |
| 5 |
Renaissance Technologies
New York
|
+$126M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$336M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$328M |
| 3 |
JP Morgan Chase
New York
|
-$187M |
| 4 |
Goldman Sachs
New York
|
-$176M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$142M |
AGN Hedge Fund Activity: Q2 2018 in Review
1,044 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2018, worth a combined $44B — down 3.9% from $45.8B a quarter earlier.
Buyers outnumbered sellers: 110 funds opened new AGN positions and 83 closed out — a net gain of 27 holders — while 367 added to existing stakes and 425 trimmed.
The largest buyer was King Street Capital Management, opening a new position worth an estimated $174M. The largest seller was Jackson Square Partners, exiting entirely with an estimated $336M sold.
- 1,044 institutional investors held Allergan plc (AGN) as of Q2 2018, up from 1,022 in Q1 2018.
- Funds reported $44B of Allergan plc stock for Q2 2018, down 3.9% quarter-over-quarter.
- 110 funds opened new Allergan plc positions in Q2 2018 and 83 closed out, a net change of +27 holders.
- The largest Allergan plc buyer in Q2 2018 was King Street Capital Management, an estimated $174M added.
- The largest Allergan plc seller in Q2 2018 was Jackson Square Partners, an estimated $336M sold.
Based on aggregated 13F filings for Q2 2018.